Organization | Canadian Anesthesiologists' Society

Canadian Anesthesiologists' Society Report issue

Academic/Hospital Phase 2 Phase 4

Founded: Toronto Canada (1943)

Organization Overview

First Clinical Trial

2006

NCT00335582

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2009

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 4 Trials (1)

clonidine (catapres) (1 trial)

Drugs in Phase 2 Trials (2)

milrinone (primacor) (1 trial)

sodium chloride (1 trial)

Drugs in Other Trials (6)

atorvastatin (lipitor) (1 trial)

dinoprost (1 trial)

ergonovine (Ergotrate) (1 trial)

misoprostol (cytotec) (1 trial)

oxytocin (syntocinon) (1 trial)

propofol (diprivan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Coronary Artery Disease (Phase 2)

Heart Diseases (Phase 4)

Hypertension, Pulmonary (Phase 2)

Ischemia (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 5
# of Trial APIs: 9